EVIDENCE
Gensco® Pharma is a specialty pharmaceutical company focusing on research, development, and marketing of transdermal prescription products. As an innovator of pharmaceutical products and the development of patented drug delivery systems, we are dedicated to the continual pursuit of novel and effective therapies that improve health.
To stay updated on our latest research, subscribe to Research Newsletter. Go to our sign up form here.
MISSION STATEMENT
Gensco® Pharma is committed to Better Science for Health.
Our resources are focused on innovative research, the development of superior quality medications and unique delivery systems. We are an evidence-based solutions company that is progressively developing products utilizing new technologies that deliver outcomes to reduce the effects caused by disease or pathology.
EVIDENCE
Latest Research Articles
Physician Explores Gout Treatment Options May 15, 2017 Articles, Clinical, Featured - As seen in Chain Drug Review | May 15, 2017 MIAMI — Gout is an extremely painful form of inflammatory arthritis and the more...
The Difference Between Topical and Transdermal Medications March 29, 2017 Clinical, Research - White Paper by Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs, Gensco Pharma Abstract Topical medications are widely used more...
Working In All Disease States and Cost Management Areas to Help Patients Access Medications March 21, 2017 Clinical, Featured, Industry - Gensco® President and CEO, Carlos Alfaras, recently moderated a Thought Interaction Pod (TIP) session at the ECRM Specialty Pharmacy EPPS on more...
Advances in Treatment of Painful Wounds November 28, 2016 Articles, Clinical, Featured - by Marc Alan Brenner, DPM, The Institute for Diabetic Foot Research As seen in Podiatry Management | November 2016 Wound management more...
Gensco’s Astero hydrogel alleviates diabetic foot ulcers November 21, 2016 Articles, Clinical - As seen in Chain Drug Review's Diabetes Care Report. Approximately 15% of people with diabetes suffer from foot ulcers, and more...
A Review and Case Study of Astero® (Lidocaine HCl 4%), a New Prescription Hydrogel for Painful Wounds November 16, 2016 Articles, Clinical, Featured - By Marc A. Brenner, DPM | Podiatry Management, Clinical Innovations, The Diabetic Foot. Wound pain has numerous, often interlinked, causes more...